ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Nanobubble-mediated co-delivery of Ce6 and miR-195 for synergized sonodynamic and checkpoint blockade combination therapy with elicitation of robust immune response in hepatocellular carcinoma

Ma, Yao; Li, Jinlin; Zhao, Yun; Hu, Bing; Liu, Yun*; Liu, Chaoqi*1; y
European Journal of Pharmaceutics and Biopharmaceutics2022-12DOI: 10.1016/j.ejpb.2022.10.017
4被引3阅读
引用收藏
分享

摘要

MicroRNAs (miRNAs) is the tiny and highly conserved noncoding RNAs, regulate gene expression at the post -transcriptional level by binding to the 3 '-UTR of target mRNAs. Several studies found that miR-195 plays an unavoidable role in the regulation of cell proliferation, cycle and apoptosis in hepatocellular carcinoma (HCC). Here, we constructed miR-195 and Chlorine e6 (Ce6) co-loading NBs (nanobubbles), making use of NBs as carriers to deliver miR-195 and Ce6 to mouse tumor models. Our results showed that the binding between PD-1 and PD-L1 was blocked by upregulating miR-195 expression. The analysis of CTL (Cytotoxic T Cell) immune activity in the treatment group was higher than the control group. Simultaneously, Ce6 was used as sono-sensitizer to induce SDT (sonodynamic therapy) and trigger ICD (immunogenic cell death) of tumor cell via generation of ROS. Recent studies have found that ICD may further enhance anti-tumor immunity against PD-L1. Results indicated that combination treatment effectively stimulated infiltration of T cell and the activation of natural killer (NK) cells as well as the maturation of dendritic cells (DCs), and the combination treatment group exibited the highest CTL killing activity. These results indicate that a stronger antitumor immunity was triggered via combination of SDT-induced tumor cell ICD and immune checkpoint blockade of PD-1/PD-L1 mediated by upregulation of miR-195. In conclusion, we have successfully constructed an efficient delivery system with great potential to provide a new strategy for synergistic immunotherapy.

学科与关键词

关键词
MiR-195Sonodynamic therapyImmunotherapyNanobubblesUltrasound
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
European Journal of Pharmaceutics and Biopharmaceutics
发表日期
2022-12
卷期
第 181 卷
页码
36-48
DOI
10.1016/j.ejpb.2022.10.017
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Medical College of Three Gorges University, Hubei Key Laboratory of the Tumor Microenvironment and Immunotherapy; Open Foundation Project of Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy [2018KZL02]

作者

  • M

    Ma, Yao (第一作者)

    1 · china three gorges univ

  • L

    Li, Jinlin

    china three gorges univ

查看全部 6 位作者收起作者
  • Z

    Zhao, Yun

    china three gorges univ

  • H

    Hu, Bing

    china three gorges univ

  • L

    Liu, Yun (通讯)

    1 · china three gorges univ

  • L

    Liu, Chaoqi (通讯)

    china three gorges univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417